Genome Editing and Cellular Therapy
Genome enhancing additionally referred to as gene enhancing is a collection of technology that supply scientists the cappotential to extrade an organism's DNA. These technology permit genetic cloth to be added, removed, or altered at specific places withinside the genome. Several processes to genome enhancing had been developed. A latest one is called CRISPR-Cas9, which is brief for clustered often interspaced brief palindromic repeats and CRISPR-related protein 9. The CRISPR-Cas9 gadget has generated a variety of pleasure withinside the clinical network due to the fact it's miles faster, cheaper, extra accurate, and extra green than different present genome enhancing strategies
Cell Therapy is described because the management of stay cells to a affected person with the goal of repairing or changing broken cells or tissues. It is predicated on a predefined cellular populace, that may both be from the identical affected person or from a specific donor. The form of healing cellular varies extensively with medical trials presently ruled through haematopoietic cells, mesenchymal signalling cells and lymphocytes, however additionally, at a decrease frequency, dendritic cells, hepatocytes, epithelial cells and diverse others are being investigated.
- The narrow-winding road to genetically engineered cell therapies
- Development of site-specific genetic engineering methods
- Clinical trials using zinc finger nucleases
- Clinical trials with TALEN technology
- Clinical trials using CRISPR technology
- Off-target effects and preclinical developments in gene editing strategies
- Future perspectives of gene edited cell therapies in the clinic
Related Conference of Genome Editing and Cellular Therapy
Genome Editing and Cellular Therapy Conference Speakers
Recommended Sessions
- Acute and Chronic Lymphocytic Leukemia
- Bone Marrow Transplantation
- Development of Hematopoietic Progenitor and Stem Cells
- Digital imaging in Hematology
- Disorders of Vascular Bleeding
- Epigenetic Mechanisms: Emerging Therapeutic Targets for Blood Disorders
- Genetics, Genomics, and Epigenetics
- Genome Editing and Cellular Therapy
- Hematologic Malignancy
- Hematology and Covid-19
- Hematology-Oncology
- Hemoglobin and Iron Metabolism
- Hemoglobinopathies
- Hemophilia
- Hemostasis and Thrombosis
- Immunology and Immunotherapies
- Multiple Myeloma and Other Plasma Cell Disorders
- Myelodysplastic and Myeloproliferative Disorders
- Pediatric Hematology
- Pharmacology of Chemotherapy
- Radiation Oncology or Cancer Therapy
- Transfusion Medicine
- Types of Blood Disorders
Related Journals
Are you interested in
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)
